ReShape Lifesciences Inc.
NASDAQ:RSLS
Debt Financing / Related
ReShape Lifesciences Enters Into Warrant Exercise Transaction For $2.5 Million In Gross Proceeds
Published: 06/17/2022 12:42 GMT
ReShape Lifesciences Inc. (RSLS) - Reshape Lifesciences Enters Into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds.
Reshape Lifesciences-agreement With Existing Accredited Investor to Exercise Outstanding Warrants to Purchase Up to 3.7 Million Shares of Common Stock.
Reshape Lifesciences-in Connection, Agreed to Reduce Exercise Price of 3.7 Million Exercised Warrants and 1.6 Million Remaining Unexercised Warrants to $0.6665.
Reshape Lifesciences-agreement With Existing Accredited Investor to Exercise Outstanding Warrants to Purchase Up to 3.7 Million Shares of Common Stock.
Reshape Lifesciences-in Connection, Agreed to Reduce Exercise Price of 3.7 Million Exercised Warrants and 1.6 Million Remaining Unexercised Warrants to $0.6665.